6-(chloromethyl)-11H-benzo[c][1]benzazepine

We are 6-(chloromethyl)-11H-benzo[c][1]benzazepine CAS:21535-44-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:6-(chloromethyl)-11H-benzo[c][1]benzazepine
CAS.NO:21535-44-4
Synonyms:6-(chloromethyl)-11H-benzo[c][1]benzazepine
6-Chloromethylmorphanthridine
 
Physical and Chemical Properties:
Density 1.19 g/cm3
Boiling Point 351ºC at 760mmHg
Molecular Formula C15H12ClN
Molecular Weight 241.71500
Flash Point 166.1ºC
Vapour Pressure 8.57E-05mmHg at 25°C
Index of Refraction 1.625
 
Specification:
Appearance:Off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Epinastine(CAS:80012-43-7)、Epinastine hydrobromide(CAS:127786-29-2) and Epinastine hydrochloride(CAS:108929-04-0).

6-(chloromethyl)-11H-benzo[c][1]benzazepine


Related News: According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.4-Fluoropyridine CAS:694-52-0 In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.(R) -3- (4- (5-broMo-2-clorobencil) fenoxi) tetrahidrofurano CAS:915095-90-8 “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”Diclorometilfenilsilano CAS:149-74-6 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.

Related Products
Product Name
(3,5-Diphenylphenyl)boronic acid View Details
Ethyl linoleate (JAN) View Details
3-(Dimethoxymethylsilyl)propylamine View Details
DL-Norleucine manufacturer 3-methylthiopropanal manufacturer 2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine manufacturer Dibutyl sulfide manufacturer 2,5-Difluorotoluene manufacturer